Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-02-10 08:22 am Purchase | 2021-12-31 | 13G | Johnson & Johnson JNJ | VANGUARD GROUP INC | 234,782,632 8.920% | 6,836,528![]() (+3.00%) | Filing History |
2022-02-07 1:32 pm Purchase | 2021-12-31 | 13G | CVRx, Inc. CVRX | JOHNSON & JOHNSON JNJ | 4,109,573 19.600% | 4,109,573![]() (New Position) | Filing History |
2022-02-01 2:42 pm Unchanged | 2021-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | JOHNSON & JOHNSON JNJ | 1,607,044 3.300% | 0 (Unchanged) | Filing History |
2022-01-31 5:49 pm Purchase | 2021-12-31 | 13G | Johnson & Johnson JNJ | BlackRock Inc. BLK | 200,021,352 7.600% | 11,510,810![]() (+6.11%) | Filing History |
2021-02-12 4:27 pm Sale | 2020-12-31 | 13G | Johnson & Johnson JNJ | STATE STREET CORP STT | 144,029,634 5.470% | -7,837,599![]() (-5.16%) | Filing History |
2021-02-10 11:10 am Sale | 2020-12-31 | 13G | Johnson & Johnson JNJ | VANGUARD GROUP INC | 227,946,104 8.660% | -351,671![]() (-0.15%) | Filing History |
2021-02-01 5:41 pm Unchanged | 2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | JOHNSON & JOHNSON JNJ | 2,449,183 5.700% | 0 (Unchanged) | Filing History |
2021-01-29 5:22 pm Sale | 2020-12-31 | 13G | Johnson & Johnson JNJ | BlackRock Inc. BLK | 188,510,542 7.200% | -4,560,846![]() (-2.36%) | Filing History |
2020-07-02 6:21 pm Purchase | 2020-06-30 | 13G | Fusion Pharmaceuticals Inc. FUSN | JOHNSON & JOHNSON JNJ | 3,759,634 9.000% | 3,759,634![]() (New Position) | Filing History |